Guggenheim S&P 500® Equal Weight Health Care ETF
NAV $130.66
Change $3.47 | 2.73%
As Of 10/21/14

Investment Objectives

Seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500 Equal Weight Index Health Care.

Net Asset Value

Net Asset Value $130.66
Change $3.47 | 2.73%


Ticker RYH
CUSIP 78355W841
Asset Class Sector
Inception Date 11/1/06
Gross Expense Ratio 0.40%
Related Index Ticker S35
Investment Adviser Security Investors, LLC.
Distributor Guggenheim Funds Distributors, LLC.


Volume 67,973
Last Sale Price $130.63
52-Week Range $132.44 / $103.87
Shares Outstanding 2,650,000
Total Net Assets $346,249,174.18

Market Close

Market Price $130.63
Premium / Discount -$0.03
Change $3.37 | 2.65%
High / Low $130.74 / $128.41

Historical Market Closes to NAV

  Days % of Total Days
Premium 986 49.18%
Discount 911 45.44%
Equal to NAV 108 5.39%
Total 2,005 100%


Number of Stocks 55
Return on Equity (quarterly 9/30/14) 17.38%
Price to Earning (P/E) 25.10
Price to Book (P/B) 3.51
Dividend Amount $0.14
Ex-Dividend Date N/A


As of 9/30/14
Standard Deviation Sharpe Ratio Beta R-Squared
10.60 2.70 1.03 99.41

Risk Definitions

Standard Deviation A statistical measure of the historical volatility of an investment, computed using 36 monthly returns. More generally, a measure of the extent to which numbers are spread around their average. The higher the number, the more volatility is to be expected.
Sharpe Ratio A risk-adjusted measure developed by William F. Sharpe, calculated using standard deviation and excess return to determine reward per unit of risk. The higher the Sharpe ratio, the better the fund's risk-adjusted performance.
Beta Beta is a statistical measure of volatility relative to the overall market, usually the S&P 500. A positive beta indicates movement in the same direction as the market, while a negative beta indicates movement inverse to the market. Beta for the market is generally considered to be 1. A beta above 1 or below -1 indicates more volatility than the market. A beta between 1 to -1 indicates less volatility than the market.
A measurement of how closely an investment's performance correlates with the performance of a benchmark, such as the S&P 500, and thus a measurement of what portion of its performance may be explained by the performance of the overall market or index. Values for R-squared range from 0 to 100, where 0 indicates no correlation and 100 indicates perfect correlation.


as of 10/21/2014
Total Assets $346,249,174
Number of Stocks 55
Percent Stock 99.76%
Percent Cash / Other 0.24%

Sectors / Industries

as of 10/21/14


as of 10/21/14

Security Name Ticker Shares
% of Net Assets Sector / Industry
CAREFUSION CORP CFN 134,160 $7,602,847.20 2.20% Health Care Equipment & Supplies
VERTEX PHARMACEUTICALS VRTX 66,928 $7,238,932.48 2.09% Biotechnology
MYLAN INC. MYL 132,251 $6,883,003.30 1.99% Pharmaceuticals
REGENERON PHARMACEUTICALS REGN 17,984 $6,852,083.84 1.98% Biotechnology
ALLERGAN INC AGN 36,772 $6,845,475.52 1.98% Pharmaceuticals
BECTON DICKINSON & CO BDX 54,733 $6,749,126.23 1.95% Health Care Equipment & Supplies
ALEXION PHARMACEUTICALS I ALXN 38,248 $6,673,319.80 1.93% Biotechnology
EDWARDS LIFESCIENCES CORP EW 62,437 $6,606,458.97 1.91% Health Care Equipment & Supplies
UNITEDHEALTH GROUP INC. UNH 72,217 $6,568,136.15 1.90% Health Care Providers & Services
WATERS CORPORATION WAT 61,148 $6,553,231.16 1.89% Life Sciences Tools & Services
AMGEN INC. AMGN 45,135 $6,503,502.15 1.88% Biotechnology
PERRIGO COMPANY PRGO 43,071 $6,467,541.36 1.87% Pharmaceuticals
HUMANA, INC. HUM 48,524 $6,466,793.48 1.87% Health Care Providers & Services
CELGENE CORPORATION CELG 68,004 $6,458,339.88 1.87% Biotechnology
MALLINCKRODT PLC MNK 72,159 $6,443,798.70 1.86% Pharmaceuticals
BRISTOL MYERS SQUIBB CO BMY 123,830 $6,432,968.50 1.86% Pharmaceuticals
INTUITIVE SURGICAL, INC. ISRG 12,946 $6,418,238.42 1.85% Health Care Equipment & Supplies
GILEAD SCIENCES, INC. GILD 60,039 $6,404,360.13 1.85% Biotechnology
MCKESSON CORPORATION MCK 32,337 $6,368,125.41 1.84% Health Care Providers & Services
PATTERSON COS INC PDCO 153,408 $6,360,295.68 1.84% Health Care Providers & Services
DAVITA, INC DVA 84,024 $6,343,812.00 1.83% Health Care Providers & Services
WELLPOINT, INC. WLP 52,468 $6,318,721.24 1.82% Health Care Providers & Services
BIOGEN IDEC, INC. BIIB 19,245 $6,288,688.65 1.82% Biotechnology
C.R. BARD, INC. BCR 42,072 $6,277,983.84 1.81% Health Care Equipment & Supplies
CERNER CORPORATION CERN 105,935 $6,269,233.30 1.81% Health Care Technology
CARDINAL HEALTH, INC. CAH 82,553 $6,259,993.99 1.81% Health Care Providers & Services
CIGNA CORPORATION CI 67,414 $6,249,951.94 1.81% Health Care Providers & Services
EXPRESS SCRIPTS HLDGS ESRX 84,406 $6,248,576.18 1.80% Health Care Providers & Services
ZOETIS INC ZTS 172,020 $6,208,201.80 1.79% Pharmaceuticals
MEDTRONIC, INC. MDT 95,470 $6,203,640.60 1.79% Health Care Equipment & Supplies
ABBOTT LABORATORIES ABT 146,269 $6,200,342.91 1.79% Health Care Equipment & Supplies
AMERISOURCEBERGEN CORP ABC 80,723 $6,184,996.26 1.79% Health Care Providers & Services
ELI LILLY & COMPANY LLY 95,353 $6,167,432.04 1.78% Pharmaceuticals
ACTAVIS PLC ACT 26,554 $6,163,980.02 1.78% Pharmaceuticals
COVIDIEN PLC COV 68,641 $6,126,209.25 1.77% Health Care Equipment & Supplies
STRYKER CORP SYK 74,571 $6,125,261.94 1.77% Health Care Equipment & Supplies
DENTSPLY INTERNATIONAL XRAY 133,127 $6,115,188.75 1.77% Health Care Equipment & Supplies
QUEST DIAGNOSTICS, INC. DGX 99,388 $6,074,594.56 1.75% Health Care Providers & Services
ABBVIE INC-W/I ABBV 107,528 $6,052,751.12 1.75% Pharmaceuticals
HOSPIRA INC HSP 118,254 $6,016,763.52 1.74% Pharmaceuticals
ZIMMER HOLDINGS INC ZMH 59,307 $6,008,985.24 1.74% Health Care Equipment & Supplies
BOSTON SCIENTIFIC CORP BSX 497,895 $5,989,676.85 1.73% Health Care Equipment & Supplies
PFIZER INC PFE 211,474 $5,980,484.72 1.73% Pharmaceuticals
JOHNSON & JOHNSON JNJ 59,511 $5,972,523.96 1.72% Pharmaceuticals
VARIAN MEDICAL SYSTEMS IN VAR 72,938 $5,969,245.92 1.72% Health Care Equipment & Supplies
THERMO FISHER SCIENTIFIC TMO 50,484 $5,968,218.48 1.72% Life Sciences Tools & Services
UNIVERSAL HEALTH SERVICES UHS 55,713 $5,959,062.48 1.72% Health Care Providers & Services
TENET HEALTHCARE CORP THC 101,151 $5,954,759.37 1.72% Health Care Providers & Services
AETNA INC AET 75,714 $5,935,220.46 1.71% Health Care Providers & Services
LABORATORY CORP OF AMERIC LH 58,521 $5,928,177.30 1.71% Health Care Providers & Services
ST. JUDE MEDICAL INC. STJ 98,663 $5,918,793.37 1.71% Health Care Equipment & Supplies
PERKINELMER PKI 139,326 $5,808,500.94 1.68% Life Sciences Tools & Services
MERCK & COMPANY, INC. MRK 104,512 $5,761,746.56 1.66% Pharmaceuticals
AGILENT TECHNOLOGIES, INC A 106,206 $5,735,124.00 1.66% Life Sciences Tools & Services
BAXTER INTERNATIONAL BAX 83,317 $5,719,712.05 1.65% Health Care Equipment & Supplies


Performance displayed represents past performance, which is no guarantee of future results. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Total returns reflect the reinvestment of all dividends. Current performance may be lower or higher than the performance data quoted. For up-to-date fund performance, including performance current to the most recent month-end, please visit the ETF performance page. ETFs are subject to third party transaction fees/commissions. Net asset value (NAV) is calculated by subtracting total liabilities from total assets, then dividing by the number of shares outstanding. Market close is the last price at which shares are traded. Fund shares may trade at, above or below NAV. For additional information, see the fund’s prospectus.

Performance results for periods under one year are short-term and may not provide an adequate basis for evaluating the performance potential of the fund over varying market conditions or economic cycles.

Sector funds may not be suitable for all investors. Investing in sector funds is more volatile than investing in broadly diversified funds, as there is a greater risk due to the concentration of the funds' holdings in issuers of similar offerings. Guggenheim Investment Equal Weight ETFs may not be suitable for all investors. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Most investors will also incur customary brokerage commissions when buying or selling shares of an ETF. Investments in securities are subject to market risks that may cause their prices to fluctuate over time. Please review a prospectus carefully for more information of the risks associated with each ETF.

Fund data is subject to change on a daily basis.

Composition is subject to change. Information provided is for illustration purposes only and may not reflect current investments by the fund. Referenced companies are not affiliated with Guggenheim Investments and Guggenheim Investments does not sponsor, endorse, sell or promote the referenced companies.

“Standard & Poor’s®”, “S&P®”, “S&P 500®”, “Standard & Poor’s 500”, “500”, “S&P MidCap 400” and “S&P SmallCap 600” are trademarks of Standard & Poor’s, LLC and have been licensed for use by Guggenheim Investments and its affiliates. Citigroup is a trademark of Citigroup Global Markets Inc. and has been licensed for use by Standard & Poor’s. The product is not sponsored, endorsed, sold or promoted by Standard & Poor’s, and neither Standard & Poor’s nor Citigroup Global Markets Inc. makes no representation regarding the advisability of investing in the product.

Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or contact us.

Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"), Guggenheim Funds Investment Advisors, LLC, ("GFIA") and Guggenheim Partners Investment Management ("GPIM") the investment advisers to the referenced funds. Securities offered through Guggenheim Funds Distributors, LLC, an affiliate of Guggenheim, SI, GFIA and GPIM.

2014 Guggenheim Investments. All Rights Reserved.
• Not FDIC Insured • No Bank Guarantee • May Lose Value